Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
Clinical trial NCT02796261 · UNKNOWN
Trial details
- NCT number
- NCT02796261
- Sponsor
- Orbus Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2023-06-01
- Enrollment
- 343
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.